| HOME >> MEDICINE >> TECHNOLOGY |
XI'AN, China, March 3, 2011 /PRNewswire-Asia-FirstCall/ -- DK Sinopharma, Inc. (OTC Bulletin Board: DKSP) ("DK Sinopharma" or the "Company"), announced today that it will present at the Rodman & Renshaw Annual China Investment Conference, to be held March 6-8, 2011, at the Le Royal Meridien Shanghai in Shanghai, China.
Professor Dongke Zhao, the founder and CEO of DKSP, will present on behalf of the Company on Tuesday, March 8, 2011, at 12:45 am. The Company management will also participate in one-on-one meetings with analysts and investors.
About DK Sinopharma, Inc. DK Sinopharma, Inc. has its headquarters in Xi'an, Shaanxi Province, China. The Company identifies, discovers, develops, manufactures and distributes both prescription and over-the counter, including both conventional and Traditional Chinese Medicines, pharmaceutical products for the treatment of some of the most common ailments and diseases. Through the Company's operating entity, Yangling Dongke Maidisen Pharmaceutical Co. Ltd., the Company currently manufactures herbal extracts and 38 pharmaceutical products in the form of capsules, tablets, granules, semisolid ointment, powder, ointment, and paste ointment. The Company focuses on providing remedies to a variety of ailments relating to respiratory, digestive, cardio-cerebral vascular, antineoplastic, bone diseases-modifying antirheumatic, gynecological, and refill nutrition systems, among others. DK Sinopharma's manufacturing facilities are based in the City of Yangling in Shaanxi Province. For more information see our website at http://www.dksinopharma.com.
Safe Harbor Statement This announcement contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact
'/>"/>
| SOURCE DK Sinopharma, Inc. Copyright©2010 PR Newswire. All rights reserved |